NCT04583202 is a NA clinical trial of Exposure to allergen in Allergic Rhinitis, sponsored by Alyatec.

Who is sponsoring NCT04583202?

NCT04583202 is sponsored by Alyatec.

What drugs are being tested in NCT04583202?

Interventions in NCT04583202: Exposure to placebo, Exposure to allergen.

What condition does NCT04583202 study?

NCT04583202 studies Allergic Rhinitis, Allergy to Pollen, Rhinoconjunctivitis.

Is NCT04583202 still recruiting?

NCT04583202 is currently completed. Last updated 9 June 2021.

Last reviewed 2021-06-09 · How we verify

NCT04583202

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber

Completed NA Last updated 9 June 2021

What this trial tests

NA trial testing Exposure to placebo in Allergic Rhinitis in 30 participants. Completed in 31 May 2021.

Timeline

24 February 2020

Primary endpoint
19 October 2020

31 May 2021

Quick facts

Lead sponsor	Alyatec
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	single
Primary purpose	basic science
Enrollment	30
Start date	24 February 2020
Primary completion	19 October 2020
Estimated completion	31 May 2021
Sites	1 location across France

Drugs / interventions tested

Exposure to placebo
Exposure to allergen

Conditions studied

Allergic Rhinitis — all drugs for Allergic Rhinitis →
Allergy to Pollen — all drugs for Allergy to Pollen →
Rhinoconjunctivitis — all drugs for Rhinoconjunctivitis →

Sponsor

Alyatec

Who can join

Adults 18 to 65, any sex, with Allergic Rhinitis or Allergy to Pollen. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the nasal and conjunctival response in subjects allergic to birch pollen during controlled exposures in the ALYATEC environmental exposure chamber (EEC)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Birch-induced allergic rhinitis: Results of exposure during nasal allergen challenge, environmental chamber, and pollen season.
Gherasim A, Dietsch F, Beck M, Domis N, et al · · 2023 · cited 12× · PMID 37520615 · DOI 10.1016/j.waojou.2023.100801

Verify or expand the search:

Other recruiting trials for Allergic Rhinitis

Currently open trials in the same condition.

NCT07453615 — Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children · NA · recruiting
NCT07419230 — Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project · NA · recruiting
NCT06960382 — Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Ast · Phase 1, PHASE2 · recruiting
NCT07455968 — Free Diving Breathing Training in Allergic Rhinitis · NA · active not recruiting
NCT07115342 — Effect of Combined Probiotics and Vitamin D on Symptoms of Allergic Rhinitis · NA · recruiting

Other Alyatec trials

Trials by the same sponsor.

NCT06104293 — Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergic to Grass · NA · completed
NCT06267261 — Efficacy of Face Mask in Reducing Respiratory Allergic Symptoms in Birch-allergic Subjects in ALYATEC Exposure Chamber · NA · completed
NCT03928561 — Efficacy of Air Cleaners in Asthmatics Allergic to Cat in ALYATEC Environmental Exposure Chamber · NA · completed
NCT04641130 — Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC · NA · completed
NCT04678063 — Validation of Strasbourg Environmental Exposure Chamber ALYATEC in Cat Allergic Subjects With Asthma · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04583202 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alyatec
Last refreshed: 9 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04583202.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing